Relationship between beta‐amyloid (Ab) plaque reduction and clinical benefit: the rationale for aducanumab approval

Published 2022 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Relationship between beta‐amyloid (Ab) plaque reduction and clinical benefit: the rationale for aducanumab approval
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume 18, Issue S10, Pages -
Publisher
Wiley
Online
2022-12-20
DOI
10.1002/alz.070011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.